GILEAD SCIENCES, INC.
MediumGILD · Nasdaq · Biological Products, (No Diagnostic Substances) · CIK 0000882095
Latest filing: · 2026-02-24
Customer concentration
Significant Customers note · revenue dependency
Top exposure
<10%
No disclosure detected
Flat
Geographic concentration
Segment reporting · geographic revenue
Top exposure
70.9%
U.S
-0.7pp YoY
Click a point to open the SEC source
Supplier concentration
Risk Factors · supply chain dependency
Dependency
Single source
Single sourceNamed
Qualitative disclosure — no % quantified (informational, not scored)
Flat
FY25
Qualitative dependency level by filing year.
Product concentration
ASC 275 · disclosed dependence on a specific product or service
Top exposure
<10%
No disclosure detected
Flat
Credit concentration
ASC 825 · concentration of credit risk note
Receivables
60%
Three Wholesalers
Flat
Click a point to open the SEC source
